Despite COVID-19, we are operating at full capacity and all project work is operating as usual.

Clinically predictive preclinical efficacy testing services at your disposal



Pharmatest Services Ltd (Pharmatest) is a contract research organization specialized in clinically predictive preclinical efficacy services in the therapeutic areas of oncology and skeletal diseases. In oncology we have special expertise in bone metastasis models.

Our services have been developed with just one goal in mind – to make your nonclinical drug development faster and more predictive. Our mission is to reduce the amount of drug candidates failing in clinical trials. Outsource your preclinical efficacy testing to Pharmatest and increase significantly the speed of your drug development with reduced costs.

Partnering with Pharmatest gives you an on-demand access to latest translational tools for lead validation and proof-of-concept studies in oncology and skeletal diseases. Please check under services for more information on our disease models.



Our primary focus is the safety of our employees, the health and welfare of the animals in our care, and the ability of our customers to continue their critical research.

Despite COVID-19, we are operating at full capacity and all project work is operating as usual. Many pre-emptive measures are in place to ensure the normal operation of our services.